| GRANT | DATE | AMOUNT | PROGRAM |
|---|---|---|---|
|
Center for Health Care Strategies, Inc.
CHCS Medicaid Access Accelerator - Phase 2 |
12.03.2025 | $3,129,296.00 | Type 1 Diabetes, Improve Outcomes |
|
Cornell University for the Joan & Sanford I. Weill Medical College of Cornell University
“Is Kono-S Anastomosis Protective of Surgical & Endoscopic Recurrence in Crohn's Disease? 10-Year RCT.” |
11.19.2025 | $1,402,545.00 | Crohn's Disease, Disease Management |
|
The Regents of the University of Colorado, Denver
Natural Protective Mechanisms of HLA-DQ6 (DQB1*06:02) against T1D Development |
11.19.2025 | $1,378,224.00 | Type 1 Diabetes, Prevent & Delay |
|
Engineering Ministries International USA
Elevating Rural Healthcare at Hwidiem |
11.19.2025 | $4,407,634.00 | Sub-Saharan Africa, Health Interventions |
|
Center for Urban Community Services, Inc.
Embedding Occupational Therapy into Permanent Supportive Housing |
11.19.2025 | $400,000.00 | New York City Regional |
|
Regents of The University of Michigan
The SYMPTOM Trials: Scalable, community-based methods for persistent IBS-like symptoms in Crohn's Disease in remission. |
11.19.2025 | $2,498,429.00 | Crohn's Disease, Therapeutics |
|
The Mayors Fund To Advance New York City
Improve Services to High-Acuity Single Adults in DHS Shelter |
11.19.2025 | $336,452.00 | New York City Regional |
|
The City of Hope
Immune regulatory mechanisms in HLA-DQ6 mediated protection from T1D |
11.19.2025 | $877,453.00 | Type 1 Diabetes, Prevent & Delay |
|
The Regents of the University of Colorado, Denver
Identifying Facilitators and Barriers to Close Disease Activity Monitoring in Treat-to-Target care in Crohn's Disease. |
11.19.2025 | $1,269,877.00 | Crohn's Disease, Disease Management |
|
The Bridge Inc.
Medically Enhanced Supportive Housing (MESH) Program |
11.05.2025 | $400,000.00 | New York City Regional |
|
Children's Hospital Corporation
Identifying Molecular Disease Mechanisms and Therapeutic Targets in Very Early Onset Inflammatory Bowel Disease-(Boston Studies) |
11.05.2025 | $2,261,115.00 | Crohn's Disease, Prevention |
|
Cedars-Sinai Medical Center
Integrative Multi-Omic and Computational Characterization to Identify Molecular Disease Mechanisms and Therapeutic Targets in Very Early Onset Inflammatory Bowel Disease and Across IBD Populations |
11.05.2025 | $222,750.00 | Crohn's Disease, Prevention |
|
Katholieke Universiteit te Leuven
Reprogramming epithelial plasticity and inflammatory architecture in pCD fistula (REPAIR-CD) |
11.05.2025 | $2,602,379.00 | Crohn's Disease, Disease Biology |
|
Cold Spring Harbor Laboratory
Hypoglycemia in Diabetes Course |
11.05.2025 | $178,200.00 | Type 1 Diabetes, Prevent & Delay |
|
Care-for-Rare America Inc
Mechanism-Based Patient Stratification and Therapeutic Target Discovery - Munich VEOIBD Program |
11.05.2025 | $1,791,671.00 | Crohn's Disease, Prevention |
|
Children's Hospital Medical Center
Towards an Improved Understanding of Stricturing Pediatric Small Bowel Crohn's Disease and a Standardized Definition |
11.05.2025 | $2,072,212.00 | Crohn's Disease, Diagnostics |
|
Vanderbilt University
Normalizing glucagon content and secretion in T1D through pharmacological restoration |
11.05.2025 | $825,000.00 | Type 1 Diabetes, Prevent & Delay |
|
The Weizmann Institute of Science
Reconstruction of the Wolfson Building for Biological Research following the Iranian missile attack |
11.05.2025 | $29,000,000.00 | Israel, Science, Tech & Med Research |
|
The Hospital for Sick Children
Identifying Molecular Disease Mechanisms and Therapeutic Targets in Very Early Onset Inflammatory Bowel Disease (Toronto Studies) |
10.21.2025 | $1,642,365.00 | Crohn's Disease, Prevention |
|
University of Utah
Induction of peripheral tolerance to beta cell antigens by specific targeting of human Langerin+ Dendritic Cells |
10.21.2025 | $393,421.00 | Type 1 Diabetes, Prevent & Delay |
|
Prev
12...153
Next
1 - 20 of 3046 results
|
|||